Does the media refer more to CTSO or AMIX?

In the previous week, Cytosorbents and Cytosorbents both had 5 articles in the media. Autonomix Medical's average media sentiment score of 0.86 beat Cytosorbents' score of -0.11 indicating that Autonomix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cytosorbents 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Autonomix Medical 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend MODD or AMIX?

Autonomix Medical has a consensus price target of $42.00, suggesting a potential upside of 484.14%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation and earnings, MODD or AMIX?

Modular Medical is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Modular Medical N/A N/A -$28.24M -$8.69 N/A Autonomix Medical N/A N/A -$16.72M -$41.57 N/A

Is MODD or AMIX more profitable?

Autonomix Medical's return on equity of -267.73% beat Modular Medical's return on equity. Company Net Margins Return on Equity Return on Assets Modular Medical N/A -292.14% -222.79% Autonomix Medical N/A -267.73% -216.75%

Does the media refer more to MODD or AMIX?

In the previous week, Autonomix Medical had 2 more articles in the media than Modular Medical. MarketBeat recorded 5 mentions for Autonomix Medical and 3 mentions for Modular Medical. Autonomix Medical's average media sentiment score of 0.86 beat Modular Medical's score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Modular Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Autonomix Medical 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AMIX or NMTC?

In the previous week, Autonomix Medical had 2 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 5 mentions for Autonomix Medical and 3 mentions for NeuroOne Medical Technologies. Autonomix Medical's average media sentiment score of 0.86 beat NeuroOne Medical Technologies' score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autonomix Medical 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeuroOne Medical Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend TMDIF or AMIX?

Autonomix Medical has a consensus price target of $42.00, indicating a potential upside of 484.14%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts clearly believe Autonomix Medical is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is TMDIF or AMIX more profitable?

Titan Medical's return on equity of -82.31% beat Autonomix Medical's return on equity. Company Net Margins Return on Equity Return on Assets Titan Medical N/A -82.31% -51.47% Autonomix Medical N/A -267.73% -216.75%

Autonomix Medical (AMIX) Competitors

$7.19 +1.82 (+33.89%)

Closing price 08/25/2026 04:00 PM Eastern

Extended Trading

$7.32 +0.13 (+1.74%)

As of 08/25/2026 05:43 PM Eastern

Compare

AMIX vs. CTSO, LFWD, MODD, NMTC, and TMDIF

Should you buy Autonomix Medical stock or one of its competitors? Autonomix Medical's main competitors and comparable companies include Cytosorbents (CTSO), Lifeward (LFWD), Modular Medical (MODD), NeuroOne Medical Technologies (NMTC), and Titan Medical (TMDIF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Autonomix Medical compare to Cytosorbents?

Cytosorbents (NASDAQ:CTSO) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.

In the previous week, Cytosorbents and Cytosorbents both had 5 articles in the media. Autonomix Medical's average media sentiment score of 0.86 beat Cytosorbents' score of -0.11 indicating that Autonomix Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cytosorbents	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Autonomix Medical	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

32.9% of Cytosorbents shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 7.8% of Cytosorbents shares are held by insiders. Comparatively, 6.2% of Autonomix Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Cytosorbents has a beta of 1.39, suggesting that its stock price is 39% more volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.17, suggesting that its stock price is 217% less volatile than the broader market.

Cytosorbents has higher revenue and earnings than Autonomix Medical. Cytosorbents is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytosorbents	$37.06M	0.60	-$8.20M	-$0.29	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$41.57	N/A

Autonomix Medical has a net margin of 0.00% compared to Cytosorbents' net margin of -48.94%. Autonomix Medical's return on equity of -267.73% beat Cytosorbents' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytosorbents	-48.94%	-431.65%	-41.94%
Autonomix Medical	N/A	-267.73%	-216.75%

Cytosorbents currently has a consensus target price of $5.38, suggesting a potential upside of 1,412.81%. Autonomix Medical has a consensus target price of $42.00, suggesting a potential upside of 484.14%. Given Cytosorbents' higher probable upside, analysts plainly believe Cytosorbents is more favorable than Autonomix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytosorbents	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Cytosorbents beats Autonomix Medical on 8 of the 12 factors compared between the two stocks.

How does Autonomix Medical compare to Lifeward?

Lifeward (NASDAQ:LFWD) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment.

Autonomix Medical has lower revenue, but higher earnings than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	0.95	-$19.91M	-$16.82	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$41.57	N/A

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 1.5% of Lifeward shares are owned by company insiders. Comparatively, 6.2% of Autonomix Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Autonomix Medical has a net margin of 0.00% compared to Lifeward's net margin of -141.28%. Lifeward's return on equity of -235.86% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-141.28%	-235.86%	-81.72%
Autonomix Medical	N/A	-267.73%	-216.75%

Lifeward presently has a consensus price target of $10.00, indicating a potential upside of 35.32%. Autonomix Medical has a consensus price target of $42.00, indicating a potential upside of 484.14%. Given Autonomix Medical's higher probable upside, analysts clearly believe Autonomix Medical is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Autonomix Medical had 4 more articles in the media than Lifeward. MarketBeat recorded 5 mentions for Autonomix Medical and 1 mentions for Lifeward. Autonomix Medical's average media sentiment score of 0.86 beat Lifeward's score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Lifeward	Neutral
Autonomix Medical	Positive

Lifeward has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.17, meaning that its stock price is 217% less volatile than the broader market.

Summary

Lifeward beats Autonomix Medical on 8 of the 15 factors compared between the two stocks.

How does Autonomix Medical compare to Modular Medical?

Modular Medical (NASDAQ:MODD) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations.

Modular Medical is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$41.57	N/A

Autonomix Medical's return on equity of -267.73% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-292.14%	-222.79%
Autonomix Medical	N/A	-267.73%	-216.75%

In the previous week, Autonomix Medical had 2 more articles in the media than Modular Medical. MarketBeat recorded 5 mentions for Autonomix Medical and 3 mentions for Modular Medical. Autonomix Medical's average media sentiment score of 0.86 beat Modular Medical's score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Modular Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Autonomix Medical	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Autonomix Medical has a consensus price target of $42.00, suggesting a potential upside of 484.14%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Autonomix Medical is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

27.5% of Modular Medical shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 7.1% of Modular Medical shares are held by company insiders. Comparatively, 6.2% of Autonomix Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Modular Medical has a beta of 0.37, meaning that its share price is 63% less volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.17, meaning that its share price is 217% less volatile than the broader market.

Summary

Autonomix Medical beats Modular Medical on 9 of the 13 factors compared between the two stocks.

How does Autonomix Medical compare to NeuroOne Medical Technologies?

Autonomix Medical (NASDAQ:AMIX) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

Autonomix Medical has a beta of -1.17, suggesting that its share price is 217% less volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

Autonomix Medical has a net margin of 0.00% compared to NeuroOne Medical Technologies' net margin of -71.50%. NeuroOne Medical Technologies' return on equity of -128.12% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-267.73%	-216.75%
NeuroOne Medical Technologies	-71.50%	-128.12%	-86.34%

In the previous week, Autonomix Medical had 2 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 5 mentions for Autonomix Medical and 3 mentions for NeuroOne Medical Technologies. Autonomix Medical's average media sentiment score of 0.86 beat NeuroOne Medical Technologies' score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Autonomix Medical	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeuroOne Medical Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Autonomix Medical currently has a consensus target price of $42.00, indicating a potential upside of 484.14%. NeuroOne Medical Technologies has a consensus target price of $7.33, indicating a potential upside of 239.51%. Given Autonomix Medical's higher probable upside, research analysts plainly believe Autonomix Medical is more favorable than NeuroOne Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by company insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

NeuroOne Medical Technologies has higher revenue and earnings than Autonomix Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$16.72M	-$41.57	N/A
NeuroOne Medical Technologies	$12.10M	1.63	-$3.61M	-$0.95	N/A

Summary

NeuroOne Medical Technologies beats Autonomix Medical on 10 of the 15 factors compared between the two stocks.

How does Autonomix Medical compare to Titan Medical?

Titan Medical (NASDAQ:TMDIF) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

In the previous week, Autonomix Medical had 5 more articles in the media than Titan Medical. MarketBeat recorded 5 mentions for Autonomix Medical and 0 mentions for Titan Medical. Autonomix Medical's average media sentiment score of 0.86 beat Titan Medical's score of 0.00 indicating that Autonomix Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Titan Medical	Neutral
Autonomix Medical	Positive

Titan Medical's return on equity of -82.31% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Autonomix Medical	N/A	-267.73%	-216.75%

Titan Medical has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	0.77	$6.95M	$0.05	2.37
Autonomix Medical	N/A	N/A	-$16.72M	-$41.57	N/A

Autonomix Medical has a consensus price target of $42.00, indicating a potential upside of 484.14%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts clearly believe Autonomix Medical is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.17, suggesting that its stock price is 217% less volatile than the broader market.

0.0% of Titan Medical shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 0.0% of Titan Medical shares are held by company insiders. Comparatively, 6.2% of Autonomix Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Titan Medical and Autonomix Medical tied by winning 7 of the 14 factors compared between the two stocks.

Get Autonomix Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMIX vs. The Competition

Export

Metric	Autonomix Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.21M	$5.96B	$7.34B	$12.72B
Dividend Yield	N/A	1.74%	2.53%	11.02%
P/E Ratio	-0.17	26.05	270.94	24.14
Price / Sales	N/A	70.20	634.76	96.68
Price / Cash	N/A	33.27	78.57	53.12
Price / Book	2.21	6.27	13.14	6.25
Net Income	-$16.72M	$149.30M	$3.46B	$347.86M
7 Day Performance	21.66%	0.30%	1.53%	0.98%
1 Month Performance	146.23%	9.22%	8.82%	5.24%
1 Year Performance	-70.48%	6.87%	26.07%	17.04%

Autonomix Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMIX Autonomix Medical	3.2265 of 5 stars	$7.19 +33.9%	$42.00 +484.1%	-66.4%	$5.21M	N/A	N/A	1	News Coverage Short Interest Decrease Gap Up High Trading Volume
CTSO Cytosorbents	2.2379 of 5 stars	$0.36 -1.1%	$5.38 +1,409.8%	-60.8%	$22.62M	$37.06M	N/A	220
LFWD Lifeward	1.9631 of 5 stars	$7.27 -1.9%	$10.00 +37.6%	-3.6%	$20.98M	$22.03M	N/A	60
MODD Modular Medical	0.1276 of 5 stars	$3.32 +9.6%	N/A	-83.4%	$18.13M	N/A	N/A	20	Upcoming Earnings Analyst Upgrade Short Interest Increase
NMTC NeuroOne Medical Technologies	1.9069 of 5 stars	$2.18 +16.0%	$7.33 +236.4%	-53.9%	$17.12M	$12.10M	N/A	20	Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AMIX) was last updated on 8/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Autonomix Medical (AMIX) Competitors

AMIX vs. CTSO, LFWD, MODD, NMTC, and TMDIF

How does Autonomix Medical compare to Cytosorbents?

Summary

How does Autonomix Medical compare to Lifeward?

Summary

How does Autonomix Medical compare to Modular Medical?

Summary

How does Autonomix Medical compare to NeuroOne Medical Technologies?

Summary

How does Autonomix Medical compare to Titan Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX vs. The Competition

Autonomix Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Autonomix Medical (AMIX) Competitors

AMIX vs. CTSO, LFWD, MODD, NMTC, and TMDIF

How does Autonomix Medical compare to Cytosorbents?

Does the media refer more to CTSO or AMIX?

Do institutionals & insiders believe in CTSO or AMIX?

Which has more volatility & risk, CTSO or AMIX?

Which has stronger earnings and valuation, CTSO or AMIX?

Is CTSO or AMIX more profitable?

Do analysts prefer CTSO or AMIX?

Summary

How does Autonomix Medical compare to Lifeward?

Which has better earnings & valuation, LFWD or AMIX?

Do institutionals & insiders have more ownership in LFWD or AMIX?

Is LFWD or AMIX more profitable?

Do analysts rate LFWD or AMIX?

Does the media refer more to LFWD or AMIX?

Which has more risk and volatility, LFWD or AMIX?

Summary

How does Autonomix Medical compare to Modular Medical?

Which has higher valuation and earnings, MODD or AMIX?

Is MODD or AMIX more profitable?

Does the media refer more to MODD or AMIX?

Do analysts recommend MODD or AMIX?

Do insiders & institutionals hold more shares of MODD or AMIX?

Which has more volatility and risk, MODD or AMIX?

Summary

How does Autonomix Medical compare to NeuroOne Medical Technologies?

Which has more risk and volatility, AMIX or NMTC?

Is AMIX or NMTC more profitable?

Does the media prefer AMIX or NMTC?

Do analysts prefer AMIX or NMTC?

Do institutionals and insiders believe in AMIX or NMTC?

Which has stronger earnings and valuation, AMIX or NMTC?

Summary

How does Autonomix Medical compare to Titan Medical?

Does the media favor TMDIF or AMIX?

Is TMDIF or AMIX more profitable?

Which has stronger earnings & valuation, TMDIF or AMIX?

Do analysts recommend TMDIF or AMIX?

Which has more risk & volatility, TMDIF or AMIX?

Do insiders and institutionals believe in TMDIF or AMIX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX vs. The Competition

Autonomix Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools